Ablate bone tumor(s) perq

CPT 20983 covers the destruction of bone tumors using minimally invasive techniques through the skin, typically using heat, cold, or radiofrequency energy instead of traditional surgery.

Showing rates for

National Average

Base Medicare rate

$4,702.21

This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.

RVU breakdown

Work RVU

6.88

PE RVU (NF)

137.69

MP RVU

0.8

Total RVU

145.37

Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High

NCCI bundling edits

Loading bundling edits…

Billing tips

Verify and document place of service accurately—billing in non-facility setting yields $4,702.21 vs. $329.61 in facility setting
Impact: $4,372.60 difference per procedure; incorrect POS coding is the single largest reimbursement error for this code
Bill imaging guidance separately (76942 for ultrasound, 77013 for CT, 77022 for MRI) as these are not bundled with 20983
Impact: Additional $150-$400 per procedure depending on imaging modality; commonly overlooked revenue
Document number of tumors ablated; if multiple distinct tumors are treated, use modifier 59 with additional units or consider multiple line items
Impact: Can double or triple reimbursement for multi-tumor ablations; requires clear anatomic documentation of separate sites
Obtain prior authorization before procedure as most payers classify percutaneous ablation as requiring pre-service review
Impact: Prevents 100% denial; authorization turnaround typically 3-7 days, so plan ahead of scheduling
Use diagnosis codes that support medical necessity (C79.51 for bone metastases, D16.x for benign bone neoplasms); avoid unspecified codes
Impact: Reduces denial rate by approximately 30%; specific tumor type and location coding essential for clean claims
Bill anesthesia separately (MAC, moderate sedation with +99153/99155, or general anesthesia) as appropriate to practice setting
Impact: Additional $200-$800 depending on anesthesia type and duration; ensure non-duplication with facility billing

Live Field Datano reports yet

Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.

Working with CPT 20983?

Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.

Help build the field knowledge

MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.

Related actions

Frequently asked questions

What is the Medicare reimbursement rate for CPT 20983 in 2025?

The 2025 Medicare national average reimbursement for CPT 20983 is $4,702.21 in the non-facility setting and $329.61 in the facility setting. The significant difference reflects that the non-facility rate includes practice expense for equipment and supplies that the facility provides when performed in a hospital or ASC.

Can CPT 20983 be billed with imaging guidance codes?

Yes, imaging guidance is separately billable with CPT 20983. Common codes include 76942 (ultrasound guidance), 77013 (CT guidance), or 77022 (MRI guidance). These are not bundled with 20983 according to CCI edits and represent distinct services that should be reported separately when performed.

How many RVUs is CPT code 20983 worth?

CPT 20983 has a total of 145.37 RVUs in 2025, consisting of 6.88 work RVUs, 137.69 non-facility practice expense RVUs (2.51 facility PE RVUs), and 0.80 malpractice RVUs. This is one of the highest RVU codes in interventional radiology.

Does CPT 20983 require prior authorization?

Most Medicare Advantage plans and commercial payers require prior authorization for CPT 20983 due to the high cost and need to establish medical necessity. Traditional Medicare does not require prior authorization but may subject claims to post-payment review. Always verify authorization requirements with the specific payer before scheduling.

What diagnosis codes are typically used with CPT 20983?

Common diagnoses include C79.51 (secondary malignant neoplasm of bone), C40.x or C41.x series (primary bone malignancies), D16.x series (benign bone neoplasms including osteoid osteoma), and M85.60 (other cyst of bone). The diagnosis must support medical necessity for ablation rather than other treatment modalities.

Can you bill CPT 20983 multiple times for multiple tumors?

CPT 20983 is described in plural form (tumors), but billing multiple units requires clear documentation of distinct, separate tumors at different anatomic sites. Use modifier 59 or XS to indicate separate lesions. Some payers may have specific policies limiting units per session, so verify coverage guidelines and document each tumor's location, size, and ablation parameters separately.

What is the global period for CPT 20983?

CPT 20983 has a 90-day global period. This means all routine postoperative care for 90 days after the procedure is included in the reimbursement. Any significant, separately identifiable E/M services during this period require modifier 24, and complications requiring return to the procedure room need modifier 78 (related) or 79 (unrelated).